A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients

NCT01370707 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

187

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Metformin
DRUG: CJ-30001/CJ-30002

Sponsor

HK inno.N Corporation